Monday, November 24, 2025 8:47:43 PM
And my point at the end of my last post to you was that based upon the fact the move would otherwise not be an economically efficient move, it therefore demonstrates, imo, the April moves were required in order to prepare for commercialization. In other words, imo, they would not have made the Unity Campus move unless they were already confident at the time regarding their MAA. (CEOs are often given enough information by regulators in order to make major next step preparations)
Follow that with the London site closing, which was further from Sawston.
Follow that with the Advent Acquisition, which allows prioritization toward the DCVax platform and its combinations.
Follow that with Eden C lab suite construction initiation, knowing Eden is dedicated to L for the foreseeable future, and L is ripe for an MHRA decision. (Again, CEOs are often informed by regulators to the extent they can start preparing for next steps)
Follow that with the London site closing, which was further from Sawston.
Follow that with the Advent Acquisition, which allows prioritization toward the DCVax platform and its combinations.
Follow that with Eden C lab suite construction initiation, knowing Eden is dedicated to L for the foreseeable future, and L is ripe for an MHRA decision. (Again, CEOs are often informed by regulators to the extent they can start preparing for next steps)
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
